Kevin Xu Joins Board of California’s Stem Cell Agency
July 17, 2023
South San Francisco, CA – The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, is pleased to announce the appointment of Kevin Xu to its Independent Citizens’ Oversight Committee (ICOC), the official governing Board of the agency.
Xu is CEO of MEBO International, an intellectual property management company responsible for managing “Human Body Regenerative Restoration Science” and Skingenix, a California-based organization exclusively working on drug development in the field of damaged organ regeneration.
“It is a privilege to join CIRM’s board,” says Xu. “I look forward to collaborating with a passionate group of experts dedicated to advancing science and research to improve lives.”
Xu brings a wealth of knowledge and leadership experience to his new role. He was appointed to serve by then California Governor Jerry Brown on the California- China Trade and Investment Advisory Group and on a key advisory board of California-China trade office. He is the Executive Board member and Co-Chair of the International Committee, Bay Area Council, a member of Los Angeles County Mental Health Commission and member of the International Policy Committee of U.S. Chamber of Commerce.
“We are delighted to welcome Kevin as an invaluable addition to the ICOC,” says Vito Imbasciani, PhD, MD, Chair of the CIRM Board. “His outstanding accomplishments, passion for innovation and dedication to advancing science align seamlessly with our mission.”
In addition to his advisory roles at several organizations, Xu serves as a member of the Clinton Global Initiative, the Forbes Non-Profit Council, the Fortune CEO Initiative and the Young Entrepreneur Council (YEC). He is the founder of the National Rongxiang Xu Foundation, the Human Heritage Project and California Fight Against Coronavirus (CFAC). He is also the director of Beijing Rongxiang Regenerative Medicine Laboratory, former member institute of the United Nations Academic Impact (UNAI), and President of International Society of Regenerative Medicine and Wound Repair (ISRMWR).
Xu earned a BA in neuroscience from the University of Southern California (USC) where he was awarded the USC Young Alumni Merit Award.
At CIRM, we never forget that we were created by the people of California to accelerate stem cell treatments to patients with unmet medical needs, and act with a sense of urgency to succeed in that mission.
To meet this challenge, our team of highly trained and experienced professionals actively partners with both academia and industry in a hands-on, entrepreneurial environment to fast track the development of today’s most promising stem cell technologies.
With $5.5 billion in funding and more than 150 active stem cell programs in our portfolio, CIRM is one of the world’s largest institutions dedicated to helping people by bringing the future of cellular medicine closer to reality.